CVS HEALTH CORPORATION (NYSE:CVS) Files An 8-K Results of Operations and Financial Condition

On February 9, 2017, CVS Health Corporation (the “Company”) issued a press release announcing its earnings for the fourth quarter and year ended December 31, 2016. Attached to this Current Report on Form 8-K as Exhibit 99.1, is a copy of the Company’s related press release dated February 9, 2017.

The information in this report is being furnished, not filed. Accordingly, the information in Item 9.01 of this report will not be incorporated by reference into any registration statement filed by the Company under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.

Item 9.01 >Financial Statements and Exhibits.

(d) Exhibits

99.1 >Press Release, dated February 9, 2017, of CVS Health Corporation

About CVS HEALTH CORPORATION (NYSE:CVS)
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics. CVS HEALTH CORPORATION (NYSE:CVS) Recent Trading Information
CVS HEALTH CORPORATION (NYSE:CVS) closed its last trading session up +0.67 at 77.03 with 6,788,496 shares trading hands.